An Open Trial of Allopurinol in Patients With Poorly Responsive Schizophrenia
Status:
Completed
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
This is a four week open label trial of ALLOPURINOL to the treatment regime of ten (10)
poorly responsive patients with schizophrenia, monitoring their response and side-effects. No
change in medication is required.